Quantcast

Latest Nephrotic syndrome Stories

2010-11-17 08:02:00

Local charity underwrites important kidney research JUPITER, Fla., Nov. 17, 2010 /PRNewswire-USNewswire/ -- The Halpin Foundation and the American Society of Nephrology (ASN) are proud to highlight the research advances in membranous nephropathy made possible by the Halpin Foundation-ASN Research Grant, created to help young faculty develop independent research careers. This award provides recipients transition funding toward successful application for an NIH RO1 grant. The Halpin...

2010-11-16 05:30:00

ANAHEIM, Calif., Nov. 16, 2010 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) announced today that it will present at the Maxim Group Growth Conference at 4:00 p.m. ET on Thursday, November 18, 2010 at the Grand Hyatt Hotel in New York. Don M. Bailey, President and Chief Executive Officer, will review the Company's business strategy and recent corporate developments. Attendance at this conference is by invitation only. A live audio and slides webcast of Questcor's...

2010-11-10 18:21:54

The Halpin Foundation and the American Society of Nephrology (ASN) proudly highlight the research advances in membranous nephropathy made possible by The Halpin Foundation-ASN Research Grant, created to help young faculty develop independent research careers. This award provides recipients transition funding toward successful application for an NIH RO1 grant. Elena Torban, PhD (McGill University Faculty of Medicine), the 2008 recipient of The Halpin Foundation-ASN Research Grant, recently...

2010-11-03 05:01:00

UNION CITY, Calif., Nov. 3, 2010 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that the commercial launch is now underway for H.P. Acthar® Gel (repository corticotropin injection) as monotherapy for the treatment of Infantile Spasms (IS) in infants and children under the age of two years. This new Acthar indication was approved by the U.S. Food and Drug Administration (FDA) on October 15, 2010. Acthar provides an important treatment...

2010-10-28 15:05:00

ANAHEIM, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today reported financial results for the quarter ended September 30, 2010. Net sales totaled $31.3 million and net income was $11.5 million or $0.18 per diluted common share for the quarter ended September 30, 2010. The Company's financial performance was driven primarily by an increase in net sales for Acthar in the treatment of acute exacerbations of multiple sclerosis (MS). Acthar net sales...

2010-10-25 05:30:00

ANAHEIM, Calif., Oct. 25 /PRNewswire-FirstCall/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) announced today that it will present at the 21st Annual Oppenheimer Healthcare Conference at 1:00 p.m. ET on Wednesday, November 3, 2010 at The Waldorf-Astoria Hotel in New York. Don M. Bailey, President and Chief Executive Officer, will review the Company's business strategy and recent corporate developments. Attendance at this conference is by invitation only. A live audio and slides...

2010-10-15 08:29:00

ANAHEIM, Calif., Oct. 15 /PRNewswire-FirstCall/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children annually. IS is a devastating and potentially life-threatening form of...

2010-09-20 05:30:00

UNION CITY, Calif., Sept. 20 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) announced today that it will present at the UBS Global Life Sciences Conference on Wednesday, September 22, 2010 at The Grand Hyatt Hotel in New York. Don M. Bailey, President and Chief Executive Officer, will discuss the Company's business strategy and historical financial performance at 3:30 p.m. Eastern Time. Attendance at this conference is by invitation only. A live audio and slides webcast of...

2010-07-29 05:30:00

UNION CITY, Calif., July 29 /PRNewswire-FirstCall/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) announced today that it will participate in the following upcoming investor conferences: The BMO Capital Markets 10th Annual Focus on Healthcare Conference Thursday, August 5, 2010 New York, NY 4:00 p.m. ET Webcast available at: http://www.bmocm.com/conferences/ 2010healthcare/webcast Collins Stewart 2010 Health Care Event Wednesday, August 11, 2010...

2010-07-28 15:05:00

UNION CITY, Calif., July 28 /PRNewswire-FirstCall/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today reported financial results for the second quarter ended June 30, 2010. The Company's financial performance was driven primarily by a 145% year-over-year increase in the number of new paid Acthar prescriptions for the treatment of multiple sclerosis (MS) exacerbations as compared to the second quarter of 2009. Net sales totaled a record $28.3 million for the quarter ended June...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related